查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
下一代測序試劑盒市場 - 2018-2028F 全球行業規模、佔有率、趨勢、機會和預測，按工作流程、測序類型、按應用、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1342716

下一代測序試劑盒市場 - 2018-2028F 全球行業規模、佔有率、趨勢、機會和預測，按工作流程、測序類型、按應用、最終用戶、地區和競爭細分

Next Generation Sequencing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Workflow, By Sequencing Type, By Usage Area, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計下一代測序試劑盒市場在預測期內將出現令人印象深刻的成長。這可以歸因於 NGS 平台的不斷進步，例如在技術中使用 iSeq 100 系統和 Ion Gene Studio S5 來更好地在全球範圍內進行測試。同樣，基於 NGS 的診斷測試的監管和報銷方案的不斷完善將進一步推動市場多年來的成長。此外，癌症患病率的不斷上升以及新一代測序在癌症和其他傳染病研究中的應用不斷增加，預計將在預測期內帶來顯著成長。此外，攜帶式測序技術的不斷發展，以及與主要參與者和研究機構在NGS技術進步方面不斷加強的伙伴關係和合作，預計將在預測期內推動市場的成長。

NGS 不斷進步

多年來，用於診斷囊性纖維化和鐮狀細胞病等一些罕見遺傳病的 DNA 檢測需求顯著增加。此外，對能夠以更低的成本提供更快結果的先進技術的需求不斷成長，預計將在預測期內推動全球下一代測序試劑盒市場的成長。

對慢性病早期檢測的需求不斷成長

為了在早期階段成功治療癌症和其他傳染病，需要NGS技術。因此，癌症和其他傳染病（如結核病、腦膜炎球菌病等）患病率的不斷上升是預計在預測期內推動 NGS 試劑盒市場成長的主要因素之一。例如，根據世界衛生組織（WHO）2022年2月提供的數據，癌症是全球主要死亡原因，2020年將導致近1000萬人死亡。因此，分子診斷方法在臨床微生物學中的使用有所增加近年來迅速發展。下一代測序 (NGS) 等分子診斷技術可以檢測核酸的存在，並且該技術速度快，不需要在培養物中培養樣本。研究人員可以使用下一代測序文本同時直接從樣本中檢測不同的疾病。此外，用NGS技術取代微陣列等傳統技術進行快速檢測將進一步增加多年來對NGS試劑盒的需求。例如，2022 年1 月，Illumina Inc. 與范德比爾特大學醫學中心(VUMC) 的全資子公司Nashville Biosciences LLC 簽訂了一項多年期協議，通過大規模基因組學和建立卓越的實驗室來加速藥物開發。使用 Illumina 的下一代測序 (NGS) 平台的臨床基因組資源。

近期發展

  • 2021年1月，華大基因地中海貧血基因檢測試劑盒獲得CE標誌批准，將用於地中海貧血等血紅蛋白病的基因診斷或普通人群攜帶者篩查。
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint藥物.

可用的客製化

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按工作流程
    • 按測序類型
    • 按使用區域
    • 按應用
    • 按最終用戶
    • 按地區

第 6 章：北美下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲下一代測序試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按工作流程（文庫製備、簇生成、測序試劑套件）
    • 按測序類型（WES 和 WGS、靶向測序、長讀測序、其他測序）
    • 按使用領域（臨床、研究）
    • 按應用（腫瘤學、罕見疾病、遺傳性疾病、生殖健康、其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室等）
    • 按國家/地區
  • MEA：國家分析
    • 南非下一代測序試劑盒
    • 沙烏地阿拉伯下一代測序試劑盒
    • 阿拉伯聯合大公國下一代測序試劑盒

第 11 章：市場動態

  • 動力
    • NGS 不斷進步
    • 對慢性病早期檢測的需求不斷成長
  • 挑戰
    • 缺乏熟練的專業人員和基礎設施
    • 嚴格的規定

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球下一代測序試劑盒市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • BGI Group.
    • Creative Biogene
    • Danaher.
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Illumina, Inc.
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer Inc.

第 16 章：戰略建議

簡介目錄
Product Code: 14801

Next Generation Sequencing Kits market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.

Growing Advancements in NGS

Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.

For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient's complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

Growing Demand for Early Detection of Chronic Diseases

For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn't require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

Market Segmentation

Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

Recent Development

  • In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
  • In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.

Market Players

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.

Report Scope

In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Kits Market, By Workflow:

  • Library Preparation
  • Cluster Generation
  • Sequencing Reagents Kits

Next Generation Sequencing Kits Market, By Sequencing Type:

  • WES and WGS
  • Targeted Sequencing
  • Long Read Sequencing
  • Other Sequencing

Next Generation Sequencing Kits Market, By Usage Area:

  • Clinical
  • Research

Next Generation Sequencing Kits, By Application:

  • Oncology
  • Rare Diseases
  • Genetic Disorders
  • Reproductive Health
  • Others

Next Generation Sequencing Kits, By End User:

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Others

Next Generation Sequencing Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 5.2.3. By Usage Area (Clinical, Research)
    • 5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Workflow
    • 5.3.2 By Sequencing Type
    • 5.3.3 By Usage Area
    • 5.3.4 By Application
    • 5.3.5 By End User
    • 5.3.6 By Region

6. North America Next Generation Sequencing Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 6.2.3. By Usage Area (Clinical, Research)
    • 6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Workflow
        • 6.3.1.2.2. By Sequencing Type
        • 6.3.1.2.3. By Usage Area
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Next Generation Sequencing Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Workflow
        • 6.3.2.2.2. By Sequencing Type
        • 6.3.2.2.3. By Usage Area
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Workflow
        • 6.3.3.2.2. By Sequencing Type
        • 6.3.3.2.3. By Usage Area
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Next Generation Sequencing Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 7.2.3. By Usage Area (Clinical, Research)
    • 7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Workflow
        • 7.3.1.2.2. By Sequencing Type
        • 7.3.1.2.3. By Usage Area
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Next Generation Sequencing Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Workflow
        • 7.3.2.2.2. By Sequencing Type
        • 7.3.2.2.3. By Usage Area
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Workflow
        • 7.3.3.2.2. By Sequencing Type
        • 7.3.3.2.3. By Usage Area
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Next Generation Sequencing Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Workflow
        • 7.3.4.2.2. By Sequencing Type
        • 7.3.4.2.3. By Usage Area
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Next Generation Sequencing Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Workflow
        • 7.3.5.2.2. By Sequencing Type
        • 7.3.5.2.3. By Usage Area
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Next Generation Sequencing Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 8.2.3. By Usage Area (Clinical, Research)
    • 8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Workflow
        • 8.3.1.2.2. By Sequencing Type
        • 8.3.1.2.3. By Usage Area
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Next Generation Sequencing Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Workflow
        • 8.3.2.2.2. By Sequencing Type
        • 8.3.2.2.3. By Usage Area
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Next Generation Sequencing Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Workflow
        • 8.3.3.2.2. By Sequencing Type
        • 8.3.3.2.3. By Usage Area
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Workflow
        • 8.3.4.2.2. By Sequencing Type
        • 8.3.4.2.3. By Usage Area
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Next Generation Sequencing Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Workflow
        • 8.3.5.2.2. By Sequencing Type
        • 8.3.5.2.3. By Usage Area
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Next Generation Sequencing Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 9.2.3. By Usage Area (Clinical, Research)
    • 9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Workflow
        • 9.3.1.2.2. By Sequencing Type
        • 9.3.1.2.3. By Usage Area
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Workflow
        • 9.3.2.2.2. By Sequencing Type
        • 9.3.2.2.3. By Usage Area
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Workflow
        • 9.3.3.2.2. By Sequencing Type
        • 9.3.3.2.3. By Usage Area
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Next Generation Sequencing Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
    • 10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
    • 10.2.3. By Usage Area (Clinical, Research)
    • 10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
    • 10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Workflow
        • 10.3.1.2.2. By Sequencing Type
        • 10.3.1.2.3. By Usage Area
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Workflow
        • 10.3.2.2.2. By Sequencing Type
        • 10.3.2.2.3. By Usage Area
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Next Generation Sequencing Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Workflow
        • 10.3.3.2.2. By Sequencing Type
        • 10.3.3.2.3. By Usage Area
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing advancement in NGS
    • 11.1.2 Growing Demand for Early Detection of Chronic Diseases
  • 11.2. Challenges
    • 11.2.1 Lack of skilled professionals and infrastructure
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
    • 15.5.1. Agilent Technologies, Inc.
    • 15.5.2. Bio-Rad Laboratories, Inc.
    • 15.5.3. BGI Group.
    • 15.5.4. Creative Biogene
    • 15.5.5. Danaher.
    • 15.5.6. F. Hoffmann-La Roche Ltd.
    • 15.5.7. Hologic, Inc.
    • 15.5.8. Illumina, Inc.
    • 15.5.9. Oxford Nanopore Technologies plc.
    • 15.5.10. Pacific Biosciences of California, Inc.
    • 15.5.11. PerkinElmer Inc.

16. Strategic Recommendations